Herpesvirus vaccines - Development, controversies, and applications

被引:21
作者
Krause, PR
Straus, SE
机构
[1] US FDA, Ctr Biol Evaluat & Res, OVRR, Lab DNA Viruses, Bethesda, MD 20892 USA
[2] NIAID, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0891-5520(05)70043-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Herpesviruses present difficult challenges in vaccine development because of their ability to evade immune clearance. Data and recommendations regarding the live-attenuated varicella vaccine are discussed. Approaches to developing vaccines to prevent herpes simplex virus (HSV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV)-associated illnesses also are considered.
引用
收藏
页码:61 / +
页数:22
相关论文
共 88 条
[1]   IMMUNITY INDUCED BY PRIMARY HUMAN CYTOMEGALOVIRUS-INFECTION PROTECTS AGAINST SECONDARY INFECTION AMONG WOMEN OF CHILDBEARING AGE [J].
ADLER, SP ;
STARR, SE ;
PLOTKIN, SA ;
HEMPFLING, SH ;
BUIS, J ;
MANNING, ML ;
BEST, AM .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :26-32
[2]  
Adler SP, 1996, INFECT AGENT DIS, V5, P29
[3]   AN ATTEMPT TO VACCINATE AGAINST HERPES SIMPLEX [J].
ANDERSON, SG ;
HAMILTON, J ;
WILLIAMS, S .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1950, 28 (05) :579-584
[4]  
ARBETER AM, 1986, PEDIATRICS, V78, P748
[5]   Varicella vaccine: The Japanese experience [J].
Asano, Y .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S310-S313
[6]  
ASANO Y, 1994, PEDIATRICS, V94, P524
[7]  
ASANO Y, 1993, PEDIATRICS, V92, P219
[8]   VIREMIA IS PRESENT IN INCUBATION PERIOD IN NONIMMUNOCOMPROMISED CHILDREN WITH VARICELLA [J].
ASANO, Y ;
ITAKURA, N ;
HIROISHI, Y ;
HIROSE, S ;
NAGAI, T ;
OZAKI, T ;
YAZAKI, T ;
YAMANISHI, K ;
TAKAHASHI, M .
JOURNAL OF PEDIATRICS, 1985, 106 (01) :69-71
[9]  
ASANO Y, 1982, BIKEN J, V25, P43
[10]  
BALFOUR HH, 1985, TRANSPLANT P, V17, P81